Form 8-K - Current report:
SEC Accession No. 0001104659-23-054551
Filing Date
2023-05-01
Accepted
2023-05-01 17:21:14
Documents
13
Period of Report
2023-04-27
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2314238d1_8k.htm   iXBRL 8-K 92945
2 EXHIBIT 10.1 tm2314238d1_ex10-1.htm EX-10.1 107959
  Complete submission text file 0001104659-23-054551.txt   409319

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA vrna-20230427.xsd EX-101.SCH 3045
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE vrna-20230427_lab.xml EX-101.LAB 34476
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE vrna-20230427_pre.xml EX-101.PRE 22603
7 EXTRACTED XBRL INSTANCE DOCUMENT tm2314238d1_8k_htm.xml XML 3611
Mailing Address 3 MORE LONDON RIVERSIDE LONDON X0 SE1 2RE
Business Address 3 MORE LONDON RIVERSIDE LONDON X0 SE1 2RE 011-44-0-2032834200
Verona Pharma plc (Filer) CIK: 0001657312 (see all company filings)

EIN.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38067 | Film No.: 23875217
SIC: 2834 Pharmaceutical Preparations